|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_on1097960447 |
003 |
OCoLC |
005 |
20231120010350.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
190421s2019 enk ob 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d N$T
|d OPELS
|d EBLCP
|d OCLCF
|d UKAHL
|d OCLCQ
|d MYG
|d TSC
|d UX1
|d VT2
|d OCLCO
|d OCLCA
|d OCLCQ
|d OCLCO
|d COM
|d OCLCQ
|
019 |
|
|
|a 1097665025
|a 1176438791
|a 1235118385
|a 1235836048
|
020 |
|
|
|a 9780128167311
|q (electronic bk.)
|
020 |
|
|
|a 0128167319
|q (electronic bk.)
|
020 |
|
|
|z 9780128163474
|
020 |
|
|
|z 012816347X
|
035 |
|
|
|a (OCoLC)1097960447
|z (OCoLC)1097665025
|z (OCoLC)1176438791
|z (OCoLC)1235118385
|z (OCoLC)1235836048
|
050 |
|
4 |
|a RC521
|
060 |
|
4 |
|a 2019 F-471
|
060 |
|
4 |
|a WM 220
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.83
|2 23
|
100 |
1 |
|
|a Farooqui, Akhlaq A.,
|e author.
|
245 |
1 |
0 |
|a Molecular mechanicsms of dementia :
|b biomarkers, neurochemistry, and therapy /
|c Akhlag A. Farooqui.
|
260 |
|
|
|a London :
|b Elsevier,
|c 2019.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed April 22, 2019)
|
520 |
|
|
|a Considerable progress has been made in neurochemical and therapeutic aspects of dementia research in recent years. Molecular and Therapeutic Aspects of Dementia presents readers with comprehensive and cutting-edge information on the neurochemical mechanisms of various types of dementias. It provides a clearly written and logically organized and comprehensive overview of molecular aspects of risk factors, symptoms, pathogenesis, biomarkers, and therapeutic strategies for various types of dementia. This book is written for the international audience of neurochemists, neuroscientists, neurologists, neuropharmacologists, and clinicians. The hope is that this discussion will not only integrate and consolidate knowledge in this field, but will jumpstart more studies on molecular mechanisms and therapeutic aspects of dementia.
|
504 |
|
|
|a Includes bibliographical references and index.
|
650 |
|
0 |
|a Dementia
|x Molecular aspects.
|
650 |
|
0 |
|a Biochemical markers.
|
650 |
1 |
2 |
|a Dementia
|x etiology
|0 (DNLM)D003704Q000209
|
650 |
2 |
2 |
|a Dementia
|x therapy
|0 (DNLM)D003704Q000628
|
650 |
2 |
2 |
|a Biomarkers
|0 (DNLM)D015415
|
650 |
2 |
2 |
|a Risk Factors
|0 (DNLM)D012307
|
650 |
|
6 |
|a D�emence
|0 (CaQQLa)201-0007383
|x Aspect mol�eculaire.
|0 (CaQQLa)201-0374959
|
650 |
|
6 |
|a Marqueurs biologiques.
|0 (CaQQLa)201-0177920
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Biochemical markers.
|2 fast
|0 (OCoLC)fst00831950
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128163474
|z Texto completo
|